Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
Nature Medicine2009Vol. 15(3), pp. 285–292
Citations Over TimeTop 10% of 2009 papers
Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr, Jerome A. Zack, Mark A. Winters, Cassy Workman, Mark Bloch, Jacob Lalezari, S. Hegewisch Becker, Lorna Thornton, Bisher Akil, Homayoon Khanlou, Robert Finlayson, Robert McFarlane, Don Smith, Roger Garsia, Dávid Ma, Matthew Law, John M. Murray, Christof von Kalle, Julie A. Ely, Sharon M Patino, Alison E. Knop, Philip Wong, Alison V. Todd, Margaret Haughton, C.J. Fuery, Janet L. Macpherson, Geoff Symonds, Louise Evans, Susan M. Pond, David A. Cooper
Related Papers
- → A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia(2002)434 cited
- → Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks(2014)391 cited
- → Conditioned Placebo Analgesia Persists When Subjects Know They Are Receiving a Placebo(2015)116 cited
- → Μελέτη της πολυπαραγοντικής αναλγησίας στο μετεγχειρητικό πόνο μετά από λαπαροσκοπική χολοκυστεκτομή(2014)
- → Near point-of-care HIV viral load testing: Uptake and utilization in suburban Yangon, Myanmar(2022)